Windsor Capital Management, LLC Abb Vie Inc. Transaction History

Windsor Capital Management, LLC

$313 Million
Q2 2024

A detailed history of Windsor Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Windsor Capital Management, LLC holds 2,434 shares of ABBV stock, worth $472,877. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,434

Previous 2,425 0.37%

Holding current value

$472,877

Previous $441,000 5.44%

% of portfolio

0.13%

Previous 0.14%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$154.79 - $180.76 $1,393 - $1,626	9 Added 0.37%	2,434 $417,000
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $18,539 - $21,123	116 Added 5.02%	2,425 $441,000
Q4 2023 Jan 09, 2024	BUY	$137.6 - $154.97 $1,376 - $1,549	10 Added 0.43%	2,309 $357,000
Q3 2023 Oct 04, 2023	BUY	$133.59 - $154.65 $1,068 - $1,237	8 Added 0.35%	2,299 $342,000
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $1,192 - $1,484	9 Added 0.39%	2,291 $308,000
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $1,156 - $1,332	8 Added 0.35%	2,282 $363,000
Q4 2022 Jan 13, 2023	BUY	$138.31 - $165.87 $79,804 - $95,706	577 Added 34.0%	2,274 $0
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $1,073 - $1,231	8 Added 0.47%	1,697 $227,000
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $1,100 - $1,399	8 Added 0.48%	1,689 $258,000
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $1,055 - $1,310	8 Added 0.48%	1,681 $272,000
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $179,730 - $227,410	1,673 New	1,673 $226,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $225,248 - $255,691	-2,117 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $25,566 - $28,482	243 Added 12.97%	2,117 $238,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $50,127 - $55,183	-490 Reduced 20.73%	1,874 $202,000
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $724 - $978	9 Added 0.38%	2,364 $253,000
Q3 2020 Oct 09, 2020	BUY	$85.91 - $100.83 $773 - $907	9 Added 0.38%	2,355 $206,000
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $172,126 - $230,330	2,346 New	2,346 $230,000
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $153,316 - $232,446	-2,377 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $171,453 - $214,524	2,377 New	2,377 $210,000
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $190,612 - $224,342	-2,471 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $645,532 - $796,114	-8,292 Reduced 77.04%	2,471 $227,000
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $31,918 - $35,483	-359 Reduced 3.23%	10,763 $1.02 Million
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $50,725 - $60,019	565 Added 5.35%	11,122 $1.03 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $137,278 - $183,829	-1,492 Reduced 12.38%	10,557 $999,000
Q4 2017 Jan 24, 2018	SELL	$89.56 - $98.21 $130,847 - $143,484	-1,461 Reduced 10.81%	12,049 $1.17 Million
Q2 2017 Aug 08, 2017	BUY	N/A	13,510	13,510 $979,000

Others Institutions Holding ABBV

# of Institutions

3,699

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Windsor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Windsor Capital Management, LLC with notifications on news.

Account

Windsor Capital Management, LLC Abb Vie Inc. Transaction History